The role of hypoxia-inducible factors in neovascular age-related macular degeneration: a gene therapy perspective
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1420-9071
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The role of hypoxia-inducible factors in neovascular age-related macular degeneration: a gene therapy perspective ; volume:77 ; number:5 ; day:31 ; month:12 ; year:2019 ; pages:819-833 ; date:3.2020
Cellular and molecular life sciences ; 77, Heft 5 (31.12.2019), 819-833, 3.2020
- Urheber
-
Mammadzada, Parviz
Corredoira, Pablo M.
André, Helder
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00018-019-03422-9
- URN
-
urn:nbn:de:101:1-2020052520102132311382
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mammadzada, Parviz
- Corredoira, Pablo M.
- André, Helder
- SpringerLink (Online service)
Ähnliche Objekte (12)
Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration
Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
Near-infrared reflectance imaging of neovascular age-related macular degeneration
Mineralocorticoid Antagonists as Adjuncts in Neovascular Age-Related Macular Degeneration
Vision protection therapy for prevention of neovascular age-related macular degeneration
Efficacy and safety of abicipar in neovascular age-related macular degeneration
Treatment of age-related neovascular macular degeneration: the patient’s perspective
Macular functional changes in patients with neovascular age-related macular degeneration receiving ranibizumab therapy (lucentis)
Influence of new societal factors on neovascular age-related macular degeneration outcomes
Pigment epithelial detachment composition indices (PEDCI) in neovascular age-related macular degeneration
Emerging therapeutic strategies for unmet need in neovascular age-related macular degeneration
Fibrosis in age-related neovascular macular degeneration in the anti-VEGF era
Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration
Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
Near-infrared reflectance imaging of neovascular age-related macular degeneration
Mineralocorticoid Antagonists as Adjuncts in Neovascular Age-Related Macular Degeneration
Vision protection therapy for prevention of neovascular age-related macular degeneration
Efficacy and safety of abicipar in neovascular age-related macular degeneration
Treatment of age-related neovascular macular degeneration: the patient’s perspective
Macular functional changes in patients with neovascular age-related macular degeneration receiving ranibizumab therapy (lucentis)
Influence of new societal factors on neovascular age-related macular degeneration outcomes
Pigment epithelial detachment composition indices (PEDCI) in neovascular age-related macular degeneration
Emerging therapeutic strategies for unmet need in neovascular age-related macular degeneration
Fibrosis in age-related neovascular macular degeneration in the anti-VEGF era
Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration
Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
Near-infrared reflectance imaging of neovascular age-related macular degeneration
Mineralocorticoid Antagonists as Adjuncts in Neovascular Age-Related Macular Degeneration
Vision protection therapy for prevention of neovascular age-related macular degeneration
Efficacy and safety of abicipar in neovascular age-related macular degeneration
Treatment of age-related neovascular macular degeneration: the patient’s perspective
Macular functional changes in patients with neovascular age-related macular degeneration receiving ranibizumab therapy (lucentis)
Influence of new societal factors on neovascular age-related macular degeneration outcomes
Pigment epithelial detachment composition indices (PEDCI) in neovascular age-related macular degeneration
Emerging therapeutic strategies for unmet need in neovascular age-related macular degeneration